Everything looks like it is lining up. FDA granting endpoint approval for Proteinuria, Amicus advising DMX already meets that as confirmed by seeing the interim results thus far, anyone completing the trial is staying on.
Genuinely seeing a run past $1 possibly to $2 by this time next year or sooner....
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
56.5¢ |
Change
0.055(10.8%) |
Mkt cap ! $333.3M | |||
| Open | High | Low | Value | Volume |
| 52.0¢ | 56.5¢ | 52.0¢ | $1.136M | 2.073M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 42908 | 56.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 57.0¢ | 31479 | 3 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| DXB (ASX) Chart |